Back to search

Article

Aicardi-Goutières syndrome type 6: report of ADAR variant and clinical outcome after ruxolitinib treatment in the neonatal period.

2024-01-24

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Aicardi-Goutières Syndrome is a monogenic type 1 interferonopathy with infantile onset, characterized by a variable degree of neurological damage. Approximately 7% of Aicardi-Goutières Syndrome cases are caused by pathogenic variants in the <italic>ADAR</italic> gene and are classified as Aicardi-Goutières Syndrome type 6. Here we present a new homozygous pathoge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f444dff4-8b16-52a1-aa90-814bcd69d032
DOI
10.21203/rs.3.rs-3854099/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aicardi-Goutières syndrome type 6: report of ADAR variant and clinical outcome after ruxolitinib treatment in the neonatal period.DOI 10.21203/rs.3.rs-3854099/v1
Select a neighboring publication to make it the new centre.